Literature DB >> 15335184

Peripheral primitive neuroectodermal tumor of the chest wall of a 69-year-old man.

Yoko Takagi-Takahashi1, Noriharu Shijubo, Gen Yamada, Eri Saitoh, Kaku Sawada, Tetsuro Ohnishi, Takayuki Itoh, Toyohiro Saikai, Tatsuru Ikeda, Sachiko Kimura, Hiroki Takahashi, Shosaku Abe.   

Abstract

We report a case of peripheral primitive neuroectodermal tumor (pPNET), which belongs to the pPNET/Ewing's sarcoma family, arising in the chest wall of a 69-year-old man. He had high levels of serum neuron-specific enolase and pro-gastrin-releasing peptide, which are believed to be useful diagnostic blood markers for small cell lung carcinoma (SCLC). Microscopically, the tumor was composed of solid nests and sheets of monotous, primitive, small round cells with a few rosettes, making it difficult to distinguish from SCLC. Immunohistochemically, the tumor cells showed intense cell membranous immunoreactivity for MIC2 protein (CD99). EWS/FLI-1 chimeric mRNA that originated from the characteristic t(11;22)(q24;q12) chromosomal translocation was detected by RT-PCR and nucleotide sequence analysis. These results confirmed the diagnostic validity of the present tumor being a pPNET, thus raising the possibility that in the past, pPNETs which have arisen in the chest have been mistakenly diagnosed as SCLC.

Entities:  

Mesh:

Year:  2004        PMID: 15335184     DOI: 10.2169/internalmedicine.43.578

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  4 in total

1.  Rare pulmonary primitive neuroectodermal tumor metastasizing to the right atrium: a case report.

Authors:  Liwei Mao; Hongmei Wang; Guoqing Xie; Na Zhang; Guoqing Liao
Journal:  Med Oncol       Date:  2012-03-06       Impact factor: 3.064

2.  Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney that responded to low-dose chemotherapy with ifosfamide, etoposide, and doxorubicin.

Authors:  Kenji Ohgaki; Kazutaka Horiuchi; Satoshi Mizutani; Mitsuhiro Sato; Yukihiro Kondo
Journal:  Int J Clin Oncol       Date:  2010-02-26       Impact factor: 3.402

3.  Pro-gastrin-releasing peptide as a marker for the Ewing sarcoma family of tumors.

Authors:  Yosuke Honda; Hirohisa Katagiri; Mitsuru Takahashi; Hideki Murata; Junji Wasa; Seiichi Hosaka; Yuji Ishida; Ichiro Ito; Koji Muramatsu; Tohru Mochizuki; Yukihiro Matsuyama; Ken Yamaguchi
Journal:  Int J Clin Oncol       Date:  2019-07-01       Impact factor: 3.402

4.  Askin tumor: CT and FDG-PET/CT imaging findings and follow-up.

Authors:  Tingting Xia; Yubao Guan; Yongxin Chen; Jingxu Li
Journal:  Medicine (Baltimore)       Date:  2014-07       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.